How to Expedite FDA Approvals of Orphan Drugs

by Thomas Peyret 350 million patients worldwide suffer from 7,000 rare diseases, yet only 300 of these diseases have approved treatments. This gap, impacting 95% of rare disease patients, represents a huge unmet medical need. Developing drugs for rare diseases poses a range of clinical, regulatory and commercial challenges. The small number of patients are … Continued

1 of 1
Back to top
Powered by Translations.com GlobalLink OneLink Software